We estimate that completing this interview will take about 25 minutes.

The principal investigators of the project are Daniel Klein and Jason Briggeman, a professor and a graduate student in the Department of Economics at George Mason University.  We are conducting online interviews of economists who work in fields relevant to pharmaceutical policy.  The interview results will be used for scholarly purposes. 

In the United States, new pharmaceuticals and medical devices are banned from the market until individually approved by the U.S. Food and Drug Administration. This policy has developed over many decades and is now a complex reality.  The immediate goal of the study is to achieve a better understanding of the rationales for the policy.  The ultimate goal is improved health and welfare for all those who can or do benefit from pharmaceuticals and medical devices.

We are grateful to you for giving your time and expertise to the project.